http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-204536-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c943e69f9a5227aedca22c003b17fbf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f699d52e2ea18d3aa528c66bac17680 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2002-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bce54c6538a17a98706f81992439474 |
| publicationDate | 2010-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PL-204536-B1 |
| titleOfInvention | Use of guinea pig myelin basic protein (GPMBP) (54) in the manufacture of a medicament, for topical administration, for the prevention or treatment of multiple sclerosis disease |
| priorityDate | 2002-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.